Filter
1750
Filtered Results: 1750
Text search:
drug
formulations
Featured
Recommendations
192
New Publications
554
Language
Document type
No document type
1054
Guidelines
305
Studies & Reports
207
Manuals
75
Strategic & Response Plan
49
Training Material
23
Fact sheets
22
Situation Updates
5
Infographics
4
Brochures
2
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
103
Kenya
71
Uganda
54
Global
47
Tanzania
43
Malawi
37
Nepal
36
South Africa
35
Ethiopia
34
Liberia
32
Sierra Leone
30
Ghana
29
Nigeria
28
Zambia
28
Rwanda
27
Bangladesh
24
Namibia
24
Philippines
22
Zimbabwe
21
Myanmar / Burma
21
Latin America and the Carribbean
20
Western and Central Europe
19
Africa
17
Cambodia
17
Senegal
12
Botswana
12
Lesotho
11
Indonesia
10
Eswatini/ Swaziland
10
South–East Asia Region
9
Cameroon
8
Haiti
7
Congo, Democratic Republic of
7
Burkina Faso
6
Eastern Europe
6
Ukraine
5
Syria
5
Asia
5
Russia
5
Benin
4
Albania
4
Pakistan
4
Tajikistan
3
Thailand
3
Mozambique
3
Eastern Europe and Central Asia
3
Georgia
3
South Sudan
3
Madagascar
3
North Macedonia
2
Timor Leste/ East Timor
2
Iran
2
Afghanistan
2
Guinea
2
USA
2
Middle East and North Africa
2
Western Pacific Region
2
North America
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Vietnam
2
Sri Lanka
2
Sudan
2
Libya
2
Colombia
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Peru
1
Malaysia
1
Morocco
1
Venezuela
1
Jordan
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Turkmenistan
1
Denmark
1
France
1
Tunisia
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Moldova
1
Yemen
1
Greece
1
Mali
1
Bhutan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
757
Clinical Guidelines
242
Women & Child Health
78
Public Health
71
Key Resources
42
Capacity Building
25
Pharmacy & Technologies
25
Toolboxes
HIV
183
TB
169
Pharmacy
110
AMR
104
Mental Health
90
NTDs
67
COVID-19
49
Malaria
39
Caregiver
28
NCDs
28
Rapid Response
25
Ebola & Marburg
21
Refugee
16
Planetary Health
12
Disability
11
Health Financing Toolbox
9
Global Health Education
8
Specific Hazards
6
Cholera
6
Conflict
6
Natural Hazards
5
Polio
5
2.0 Rapid Response
4
Zika
4
Social Ethics
3
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants ...
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting of the NSP and the prin...
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally....
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
This updated version, endorsed by the World Health Assembly in May 2021 through resolution WHA74.9, reflects lessons learned in the global malaria response over the last 5 years. While the milestones and targets remain the same, the approaches to tackling the disease, in some areas, have evolved to ...
October 2009 | Volume 6 | Issue 10 | e1000162
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
